Bloomage Biotech Establishes Medical Device Sales Company in Beijing with 5 Million RMB Capital
Bloomage Biotech has established a new subsidiary, Beijing Bloomage Medical Device Sales Co., Ltd., in Beijing. The company's registered capital is 5 million RMB. Sun Jingjun serves as the legal representative. The business scope includes the sale of Class II medical devices, wholesale and retail of cosmetics, and sales of health foods. Beijing Bloomage Haiyu Technology Co., Ltd. is the sole shareholder of the new entity. This move by Bloomage Biotech, a prominent player in the biotechnology and cosmetics industries, signals an expansion into the medical device sector.
The establishment of Beijing Bloomage Medical Device Sales Co., Ltd. by Bloomage Biotech indicates a strategic diversification into the healthcare market. This expansion aligns with broader industry trends where biotechnology firms leverage their expertise in areas like hyaluronic acid for medical applications. The inclusion of cosmetics and health foods in the business scope suggests an integrated approach to health and wellness products. Future success will likely depend on navigating the regulatory landscape for medical devices and effectively integrating these new offerings with Bloomage's existing brand portfolio and distribution channels.
AI-generated to prompt reflection — not editorial opinion, not advice, not a statement of fact. How this works.